MedTrace Logo

Efficacy of the SeQuent®Please in the Treatment of De-novo Stenoses Versus Taxus™Liberté™

NCT01084408 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2021-03-25

No results posted yet for this study

Summary

The aim of the trial is to assess the efficacy of the Paclitaxel-coated SeQuent®Please angioplasty balloon in the treatment of stenoses in native coronary arteries compared to a drug eluting stent.

Conditions

  • Coronary De-novo Stenoses

Interventions

DEVICE

SeQuent®Please (Paclitaxel coated balloon)

PCI of de-novo lesions

DEVICE

Taxus™Liberté™ (Paclitaxel eluting stent)

PCI of de-novo lesions

Sponsors & Collaborators

  • University Hospital, Saarland

    lead OTHER

Principal Investigators

  • Bruno Scheller, Prof. Dr. med · Uniklinikum des Saarlandes

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-01
Primary Completion
2012-03-01
Completion
2013-03-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01084408 on ClinicalTrials.gov